Digirad gets FDA approval for SPECT/CT imaging system

03/26/2009 | AuntMinnie.com (free registration)

The FDA has given 510(k) clearance to Digirad to market its Cardius X-ACT imaging system. The cardiac SPECT/CT device is capable of low-dose VCT attenuation correction to limit artifacts in images due to overlying tissues. It features a 24-inch-wide detector array and triple-head solid-state digital detectors.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA